Severe acute respiratory syndrome (SARS) in Hong Kong.
Severe acute respiratory syndrome (SARS) is a recently recognized and highly contagious pneumonic illness, caused by a novel coronavirus. While developments in diagnostic, clinical and other aspects of SARS research are well underway, there is still great difficulty for frontline clinicians as validated rapid diagnostic tests or effective treatment regimens are lacking. This article attempts to summarize some of the recent developments in this newly recognized condition from the Asia Pacific perspective.
Tsang
Kenneth W
KW
University Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, China. kwttsang@hku.hk
Mok
Thomas Y
TY
Wong
Poon C
PC
Ooi
Gaik C
GC
D000998:Antiviral Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004196:Disease Outbreaks; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D017053:Infection Control; D010356:Patient Isolation; D012254:Ribavirin / Q000627:therapeutic use; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy / Q000635:transmission
D000998:Antiviral Agents; D012254:Ribavirin